New diabetes medicines funded: empagliflozin and dulaglutide

Sodium-glucose co-transporter 2 (SGLT-2) inhibitors and glucagon-like...

A rising tide of type 2 diabetes in younger people: what can primary care do?

An increasing incidence of early onset type 2 diabetes in New...

The annual diabetes review: screening, monitoring and managing complications

An annual diabetes review allows for assessment of glycaemic...

Initiating insulin for people with type 2 diabetes

Due to its progressive nature, many people with type 2 diabetes...

Prescribing vildagliptin for type 2 diabetes

With two new medicines, empagliflozin and dulaglutide, available...

Weight loss for the prevention and treatment of type 2 diabetes

Obesity is contributing to the increasing rate of type 2 diabetes...

Type 2 diabetes management toolbox: from lifestyle to insulin

The management of type 2 diabetes is multi-faceted, including...

Clinician’s Notepad: type 2 diabetes

Prescribing report: A pharmacological profile of patients with type 2 diabetes

This report provides an overview of the clinical characteristics...

National report: A pharmacological profile of patients with type 2 diabetes

This report provides an overview of the clinical characteristics...

Knowing your patient with type 1 diabetes: the transition to self-management

Living with type 1 diabetes is challenging, particularly as...

Understanding the role of insulin in the management of type 1 diabetes

Insulin treatment is an essential component of type 1 diabetes...

Slowing progression of renal dysfunction in patients with diabetes

Diabetic kidney disease (DKD) is the leading cause of end-stage...

Dialling back treatment intensity for older people with type 2 diabetes

Type 2 diabetes management in older people can be complex due...

Weight loss: the options and the evidence

The benefits of intentional weight loss in people who are overweight...

Optimising pharmacological management of HbA_1c levels in patients with type 2 diabetes: from metformin to insulin

A variety of subsidised medicines are available to help manage...

Vildagliptin: a new treatment for type 2 diabetes

Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor available...

A rising tide of type 2 diabetes in younger people: what can primary care do?

An increasing incidence of early onset type 2 diabetes in New...

Managing patients with type 2 diabetes: from lifestyle to insulin

Managing patients with type 2 diabetes: from lifestyle to insulin

The management of type 2 diabetes is multi-faceted. Following...

Annual Diabetes Review

This report uses data from the pharmaceutical collection and...

Monitoring diabetes before, during and after pregnancy

Hyperglycaemia during pregnancy is associated with a range of...

Assessing diabetic peripheral neuropathy in primary care

Diabetic peripheral neuropathy is one of the most common long-term...

The year that was: Key messages from Best Practice Journal 2013

2013 began with publication of the 50th issue of Best Practice...

Getting to know patients with type 2 diabetes and poor glycaemic control: One size does not fit all

People with type 2 diabetes and poor glycaemic control (HbA1c...

Improving glycaemic control in people with type 2 diabetes: Expanding the primary care toolbox

Most people with type 2 diabetes require regular and intensive...

News updates

Comparing results between different blood glucose meters | Beating...

Update: It is now time to change your patient's diabetes meter

ON 1 SEPTEMBER 2012, three new diabetes blood glucose meters...

Which test should I use to diagnose type 2 diabetes?

This report presents how testing for diabetes has changed since...

When to use fasting glucose to diagnose people with type II diabetes

Until recently, fasting plasma glucose, and in some situations,...

Initiating interventions in people with intermediate hyperglycaemia ("pre-diabetes")

Intermediate hyperglycaemia is a biochemical state in which...

Care pathways for long-term conditions: Using type 2 diabetes as an example

A care pathway is a tool that enables practitioners to provide...

Funding changes to diabetes management products announced

This article has been archived. If you would like access...

Monitoring diabetes in people over 75

In the March 2012 issue of Best Tests, bpacnz published an article...

Upfront: The new face of diabetes care in New Zealand

ON 1 JULY, 2012 the “Get Checked” programme, under which diabetes...

Testing for CVD, diabetes and renal disease in elderly people

Consideration of laboratory testing and interpretation of subsequent...

The new role of HbA_1c in diagnosing type 2 diabetes

A position statement released by the New Zealand Society for...

Initiating insulin for people with type 2 diabetes

Due to its progressive nature, many people with type 2 diabetes...

PHO Performance Programme - six years on

The PHO Performance Programme was established in 2005 to improve...

Diabetes follow-up: what are the PHO Performance Programme indicators and how are they best achieved?

The purpose of the PHO Performance Programme is to improve health...

News in brief: HbA_1c reporting and diabetes resources

As of 1 October 2011, laboratories are reporting HbA1c results...

Diabetes detection: what are the PHO Performance Programme indicators and how are they best achieved?

The purpose of the PHO Performance Programme is to improve health...

Gout: an alarm bell for diabetes and cardiovascular disease

Counties Manukau DHB Māori Gout Action Group have identified...

Testing patients with diabetes

Examines HbA1c and albumin/creatinine ratio testing rates for...

Screening and management of “The Diabetic Foot”

Foot ulceration and damage is one of the most common complications...

Snippets: Insulin glargine & Ezetimibe

This article has been archived. If you would like access...

HbA_1c targets in people with type 2 diabetes - do they matter?

Maintaining good glycaemic control reduces the risk of microvascular...

Screening for diabetic retinopathy in primary care

Sight-threatening retinopathy is a serious complication of diabetes...

Snippets: Gabapentin Humalog & Tramadol

Humalog, Tramadol and Gabapentin

Upfront: Discussing weight loss in general practice

New Zealanders are getting fatter. That’s a fact. When a problem...

Changes to laboratory reporting of HbA_1c

A short article covering changes in HbA1c test reporting from...

The use of insulin in type 2 diabetes

There is evidence that early use of insulin in people with type...

Metabolic syndrome: useful or not?

Debate about the clinical usefulness of a diagnosis of metabolic...

The nutritional management of diabetes

Managing diet is a priority for the health and wellbeing of...

Self monitoring of blood glucose: An update

New evidence concludes that self monitoring of blood glucose...

Cardiovascular disease and diabetes in Māori

Cardiovascular disease and type II diabetes are major causes...

Self monitoring in diabetes

Self-monitoring of blood glucose (SMBG) is an important component...